Admera Health Launches Molecular Test for Inherited Early Atherosclerosis Diagnosis and Risk SOUTH PLAINFIELD, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Admera Health (www.admerahealth.com), a commercial stage New Jersey based Precision Medicine and Digital Health company announced today the...

Cholesterol-Lowering Injectables: More Harm Than Good, States Journal of American Physicians and Surgeons TUCSON, Ariz., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Newly approved cholesterol lowering agents, Repatha (evolocumab) and Praluent (alirocumab), are being heavily promoted as a new breakthrough in...